Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling

Diabetes mellitus (DM)-induced glucolipotoxicity is an element strongly contributing to alveolar bone deficiency. Parathyroid hormone (PTH) has been recognized as a predominant systemic mediator to stability physiological calcium in bone. This research aimed to uncover PTH’s potential position in ameliorating the osteogenic capability of human bone marrow mesenchymal stem cells (HBMSCs) in opposition to glucolipotoxicity. Optimum PTH concentrations and excessive glucose and palmitic acid (GP) had been administered to cells, adopted by alkaline phosphatase (ALP) staining and ALP exercise assay.

Quantitative real-time reverse transcription-polymerase chain response (qRT-PCR) and Immunoblot had been carried out for assessing mRNA and protein quantities, respectively. Cell counting equipment-8 (CCK-8) and circulate cytometry had been carried out for quantitating cell proliferation. Osteogenesis and oxidative stress had been decided, and the involvement of mitogen-activated protein kinase (MAPK) signaling was additional verified. About 1-50 mmol/ml GP considerably inhibited the osteogenic differentiation of HBMSCs. 10-9 mol/L PTH was discovered to be the optimum focus for HBMSC induction. PTH had no results on HBMSC proliferation, with or with out GP therapy.

PTH reversed insufficient osteogenesis and extreme oxidative stress in GP-treated HBMSCs. Mechanistically, PTH activated p38 MAPK signaling, whereas inhibiting p38 MAPK-suppressed PTH’s useful impacts on HBMSCs. Collectively, PTH promotes osteogenic differentiation in HBMSCs in opposition to glucolipotoxicity by way of p38 MAPK signaling.

 

MiR-139-5p Upregulation Alleviated Spontaneous Recurrent Epileptiform Discharge-induced Oxidative Stress and Apoptosis in Rat Hippocampal Neurons by way of Regulating the Notch Pathway

Epilepsy was characterised by the prevalence of spontaneous recurrent epileptiform discharges (SREDs) in neurons. Earlier research urged that microRNA (miR)-139-5p and the Notch pathway had been implicated in Epilepsy; nevertheless, their interplay remained imprecise. Rat main hippocampal neurons had been remoted and recognized by immunofluorescence staining.
The cells had been then used for SREDs mannequin development and additional subjected to circulate cytometry for apoptosis detection. Contents of lactate dehydrogenase (LDH), malondialdehyde (MDA), tremendous oxidase dismutase (SOD) contents, and reactive oxygen species (ROS) and the extent of mitochondrial membrane potential (MMP) had been decided utilizing industrial kits. Goal gene and potential binding websites of miR-139-5p had been predicted with TargetScan and confirmed by dual-luciferase reporter assay. Expressions of miR-139-5p, Notch pathway-related proteins and apoptosis-related proteins had been measured by quantitative real-time polymerase chain response (qRT-PCR) and Western blot as wanted. The outcomes confirmed that the hippocampal neurons had been microtubule-associated protein 2 (MAP2)-positive. MiR-139-5p was downregulated in SREDs mannequin cells.
SREDs promoted apoptosis and elevated the contents of LDH, MDA, and ROS and the extent of MMP whereas lowering miR-139-5p expression and SOD content material in cells, which was reversed by miR-139-5p overexpression. Notch-1 was acknowledged because the goal gene of miR-139-5p, and its expression was negatively regulated by miR-139-5p. Apart from, Notch-1 overexpression reversed the consequences of miR-139-5p upregulation on the expressions of Notch pathway-related proteins and apoptosis-related proteins, cell apoptosis, oxidative stress and MMP in SREDs-treated cells. Our outcomes indicated that miR-139-5p upregulation alleviated SREDs-induced oxidative stress and cell apoptosis by way of regulating the Notch pathway, which supplies new insights into the position of miRNA within the prevalence and improvement of epilepsy. This text is protected by copyright. All rights reserved.
Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling
Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling

A serological framework to analyze acute main and post-primary dengue circumstances reporting throughout the Philippines

Background: In dengue-endemic nations, concentrating on restricted management interventions to populations vulnerable to extreme illness may allow elevated effectivity. People who’ve had their first (main) dengue an infection are vulnerable to creating extra extreme secondary illness, thus might be focused for illness prevention. At the moment, there is no such thing as a dependable algorithm for figuring out main and post-primary (an infection with a couple of flavivirus) standing from a single serum pattern. On this research, we developed and validated an immune standing algorithm utilizing single acute serum samples from reporting sufferers and investigated dengue immuno-epidemiological patterns throughout the Philippines.
Strategies: Throughout 2015/2016, a cross-sectional pattern of 10,137 dengue case experiences supplied serum for molecular (anti-DENV PCR) and serological (anti-DENV IgM/G seize ELISA) assay. Utilizing combination modelling, we re-assessed IgM/G seroprevalence and estimated purposeful, illness day-specific, IgG:IgM ratios that categorised the reporting inhabitants as adverse, historic, main and post-primary for dengue. We validated our algorithm in opposition to WHO gold commonplace standards and investigated cross-reactivity with Zika by assaying a random subset for anti-ZIKV IgM and IgG. Lastly, utilizing our algorithm, we explored immuno-epidemiological patterns of dengue throughout the Philippines.
Outcomes: Our modelled IgM and IgG seroprevalence thresholds had been decrease than kit-provided thresholds. People anti-DENV PCR+ or IgM+ had been labeled as lively dengue infections (83.1%, 6998/8425). IgG- and IgG+ lively dengue infections on illness days 1 and a pair of had been categorised as main and post-primary, respectively, whereas these on illness days three to five with IgG:IgM ratios beneath and above 0.45 had been labeled as main and post-primary, respectively. A big proportion of post-primary dengue infections had elevated anti-ZIKV IgG inferring earlier Zika publicity. Our algorithm achieved 90.5% serological settlement with WHO commonplace apply. Submit-primary dengue infections had been extra prone to be older and current with extreme signs. Lastly, we recognized a spatio-temporal cluster of main dengue case reporting in northern Luzon throughout 2016.

Arylformamidase (AFMID) Antibody

20-abx175476
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Arylformamidase (AFMID) Antibody

20-abx171327
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Arylformamidase (AFMID) Antibody

abx230202-100g 100 µg
EUR 350

AFMID Antibody (N-term)

MBS9204297-008mL 0.08mL
EUR 210

AFMID Antibody (N-term)

MBS9204297-04mL 0.4mL
EUR 430

AFMID Antibody (N-term)

MBS9204297-5x04mL 5x0.4mL
EUR 1910

(DANRE) afmid Antibody (N-term)

MBS9210967-008mL 0.08mL
EUR 210

(DANRE) afmid Antibody (N-term)

MBS9210967-04mL 0.4mL
EUR 430

(DANRE) afmid Antibody (N-term)

MBS9210967-5x04mL 5x0.4mL
EUR 1910

AFMID Polyclonal Antibody

28578 100ul
EUR 439

AFMID Polyclonal Antibody

28578-100ul 100ul
EUR 302.4

AFMID Polyclonal Antibody

28578-50ul 50ul
EUR 224.4

AFMID Polyclonal Antibody

E914441 100ul
EUR 225
Description: Available in various conjugation types.

AFMID Polyclonal Antibody

E-AB-90847-120uL 120uL
EUR 320
Description: Unconjugated

AFMID Polyclonal Antibody

E-AB-90847-200uL 200uL
EUR 530
Description: Unconjugated

AFMID Polyclonal Antibody

E-AB-90847-60uL 60uL
EUR 200
Description: Unconjugated

AFMID Polyclonal Antibody

E-AB-90847-each each Ask for price
Description: Unconjugated

AFMID Polyclonal Antibody

MBS9134444-002mL 0.02mL
EUR 200

AFMID Polyclonal Antibody

MBS9134444-005mL 0.05mL
EUR 255

AFMID Polyclonal Antibody

MBS9134444-01mL 0.1mL
EUR 345

AFMID Polyclonal Antibody

MBS9134444-02mL 0.2mL
EUR 545

AFMID Polyclonal Antibody

MBS9134444-5x02mL 5x0.2mL
EUR 2265

AFMID Polyclonal Antibody

MBS8569133-01mL 0.1mL
EUR 305

AFMID Polyclonal Antibody

MBS8569133-01mLAF405L 0.1mL(AF405L)
EUR 565

AFMID Polyclonal Antibody

MBS8569133-01mLAF405S 0.1mL(AF405S)
EUR 565

AFMID Polyclonal Antibody

MBS8569133-01mLAF610 0.1mL(AF610)
EUR 565

AFMID Polyclonal Antibody

MBS8569133-01mLAF635 0.1mL(AF635)
EUR 565

AFMID Polyclonal Antibody

MBS9432172-005mL 0.05mL
EUR 300

AFMID Polyclonal Antibody

MBS9432172-01mL 0.1mL
EUR 390

AFMID Polyclonal Antibody

MBS9432172-5x01mL 5x0.1mL
EUR 1610

AFMID Antibody (N-term) Blocking Peptide

MBS9228059-INQUIRE INQUIRE Ask for price

AFMID Polyclonal Conjugated Antibody

C28578 100ul
EUR 476.4

AFMID Polyclonal Conjugated Antibody

MBS9440176-01mLAF350 0.1mL(AF350)
EUR 480

AFMID Polyclonal Conjugated Antibody

MBS9440176-01mLAF405 0.1mL(AF405)
EUR 480

AFMID Polyclonal Conjugated Antibody

MBS9440176-01mLAF488 0.1mL(AF488)
EUR 480

AFMID Polyclonal Conjugated Antibody

MBS9440176-01mLAF555 0.1mL(AF555)
EUR 480

AFMID Polyclonal Conjugated Antibody

MBS9440176-01mLBiotin 0.1mL(Biotin)
EUR 480

OAAB05766-400UL - AFMID Antibody - N-terminal region

OAAB05766-400UL 400ul
EUR 389

OAAB18657-400UL - AFMID Antibody - N-terminal region

OAAB18657-400UL 400ul
EUR 409

AFMID

CSB-CL714394HU 10 μg plasmid + 200μl Glycerol Ask for price

Afmid (GFP-tagged) - Mouse arylformamidase (Afmid)

MG204269 10 µg Ask for price

Afmid (untagged) - Mouse arylformamidase (Afmid), (10ug)

MC211197 10 µg Ask for price

(DANRE) afmid (N-term) Rabbit Polyclonal Antibody

E10G32699 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Afmid (Myc-DDK-tagged) - Mouse arylformamidase (Afmid)

MR204269 10 µg Ask for price

AFMID siRNA

20-abx906957
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

AFMID siRNA

20-abx906958
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Afmid (untagged ORF) - Rat arylformamidase (Afmid), (10 ug)

RN205855 10 µg Ask for price

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase)

MBS643270-02mL 0.2mL
EUR 695

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase)

MBS643270-5x02mL 5x0.2mL
EUR 2975

AFMID (untagged)-Human arylformamidase (AFMID), transcript variant 2

SC301556 10 µg Ask for price

AFMID (N-term) rabbit polyclonal antibody, Aff - Purified

AP50106PU-N 400 µl Ask for price

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (AP)

MBS6272113-02mL 0.2mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (AP)

MBS6272113-5x02mL 5x0.2mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (APC)

MBS6272114-02mL 0.2mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (APC)

MBS6272114-5x02mL 5x0.2mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (PE)

MBS6272123-02mL 0.2mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (PE)

MBS6272123-5x02mL 5x0.2mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (FITC)

MBS6272116-02mL 0.2mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (FITC)

MBS6272116-5x02mL 5x0.2mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (Biotin)

MBS6272115-02mL 0.2mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (Biotin)

MBS6272115-5x02mL 5x0.2mL
EUR 4250

AFMID Rabbit pAb

A14441-100ul 100 ul
EUR 369.6

AFMID Rabbit pAb

A14441-200ul 200 ul
EUR 550.8

AFMID Rabbit pAb

A14441-20ul 20 ul
EUR 219.6

AFMID Rabbit pAb

A14441-50ul 50 ul
EUR 267.6

AFMID cDNA Clone

MBS1268376-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 320

AFMID cDNA Clone

MBS1268376-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 1395

AFMID Rabbit pAb

A14441 200μL
EUR 1246.96

Afmid (Myc-DDK-tagged ORF) - Rat arylformamidase (Afmid), (10 ug)

RR205855 10 µg Ask for price

AFMID siRNA (Mouse)

MBS8201147-15nmol 15nmol
EUR 405

AFMID siRNA (Mouse)

MBS8201147-30nmol 30nmol
EUR 565

AFMID siRNA (Mouse)

MBS8201147-5x30nmol 5x30nmol
EUR 2450

AFMID siRNA (Human)

MBS8212349-15nmol 15nmol
EUR 405

AFMID siRNA (Human)

MBS8212349-30nmol 30nmol
EUR 565

AFMID siRNA (Human)

MBS8212349-5x30nmol 5x30nmol
EUR 2450

AFMID (untagged)-Human arylformamidase (AFMID), transcript variant 2, mRNA

SC326555 10 µg Ask for price

AFMID (GFP-tagged) - Human arylformamidase (AFMID), transcript variant 1

RG227526 10 µg Ask for price

AFMID (GFP-tagged) - Human arylformamidase (AFMID), transcript variant 2

RG217126 10 µg Ask for price

Lenti ORF clone of Afmid (mGFP-tagged) - Mouse arylformamidase (Afmid)

MR204269L4 10 µg Ask for price

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 405)

MBS6272118-01mL 0.1mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 405)

MBS6272118-5x01mL 5x0.1mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 490)

MBS6272119-01mL 0.1mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 490)

MBS6272119-5x01mL 5x0.1mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 550)

MBS6272120-01mL 0.1mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 550)

MBS6272120-5x01mL 5x0.1mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 650)

MBS6272121-01mL 0.1mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 650)

MBS6272121-5x01mL 5x0.1mL
EUR 4250

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 750)

MBS6272122-01mL 0.1mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (MaxLight 750)

MBS6272122-5x01mL 5x0.1mL
EUR 4250

AFMID cloning plasmid

CSB-CL714394HU-10ug 10ug
EUR 436.8
Description: A cloning plasmid for the AFMID gene.

AFMID Blocking Peptide

DF12814-BP 1mg
EUR 234

AFMID Blocking Peptide

MBS9621518-1mg 1mg
EUR 380

AFMID Blocking Peptide

MBS9621518-5x1mg 5x1mg
EUR 1650

Recombinant Human AFMID

MBS7615831-005mg 0.05mg
EUR 345

Recombinant Human AFMID

MBS7615831-02mg 0.2mg
EUR 635

Recombinant Human AFMID

MBS7615831-1mg 1mg
EUR 1800

Recombinant Human AFMID

MBS7615831-5x1mg 5x1mg
EUR 6955

AFMID (Myc-DDK-tagged)-Human arylformamidase (AFMID), transcript variant 2

RC217126 10 µg Ask for price

AFMID (Myc-DDK-tagged)-Human arylformamidase (AFMID), transcript variant 1

RC227526 10 µg Ask for price

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (Azide free) (HRP)

MBS6272117-02mL 0.2mL
EUR 980

AFMID, NT (AFMID, Probable arylformamidase, Kynurenine formamidase) (Azide free) (HRP)

MBS6272117-5x02mL 5x0.2mL
EUR 4250

Lenti ORF clone of Afmid (Myc-DDK-tagged) - Mouse arylformamidase (Afmid)

MR204269L3 10 µg Ask for price

Human AFMID ELISA KIT

EF007651 96tests
EUR 566

Recombinant Arylformamidase (AFMID)

RPU57676-100ug 100ug
EUR 470.4

Recombinant Arylformamidase (AFMID)

RPU57676-1mg 1mg
EUR 2184

Recombinant Arylformamidase (AFMID)

RPU57676-50ug 50ug
EUR 385

Recombinant Arylformamidase (AFMID)

RPJ665Hu01 10ug
EUR 140

Recombinant Arylformamidase (AFMID)

MBS2123889-001mg 0.01mg
EUR 155

Recombinant Arylformamidase (AFMID)

MBS2123889-005mg 0.05mg
EUR 260

Recombinant Arylformamidase (AFMID)

MBS2123889-01mg 0.1mg
EUR 375

Recombinant Arylformamidase (AFMID)

MBS2123889-02mg 0.2mg
EUR 460

Recombinant Arylformamidase (AFMID)

MBS2123889-05mg 0.5mg
EUR 860

Lenti ORF particles, Afmid (GFP-tagged) - Mouse arylformamidase (Afmid), 200ul, >10^7 TU/mL

MR204269L4V 200 µl Ask for price

Mouse AFMID shRNA Plasmid

20-abx977430
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human AFMID shRNA Plasmid

20-abx964802
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human AFMID Protein Lysate

MBS136978-002mg 0.02mg
EUR 365

Human AFMID Protein Lysate

MBS136978-5x002mg 5x0.02mg
EUR 1410

Lenti ORF clone of Afmid (mGFP-tagged ORF) - Rat arylformamidase (Afmid), (10 ug)

RR205855L4 10 µg Ask for price

AFMID (NM_001010982) Human Over-expression Lysate

LS125061 100ug
EUR 628
Description: Transient overexpression lysate of arylformamidase (AFMID), transcript variant 1

Lenti ORF particles, Afmid (GFP-tagged ORF) - Rat arylformamidase (Afmid), 200ul, >10^7 TU/mL

RR205855L4V 200 µl Ask for price

AFMID Recombinant Protein (Rat)

RP189482 100 ug Ask for price

Lenti ORF particles, Afmid (Myc-DDK-tagged) - Mouse arylformamidase (Afmid), 200ul, >10^7 TU/mL

MR204269L3V 200 µl Ask for price

AFMID Recombinant Protein (Human)

RP036508 100 ug Ask for price

AFMID Recombinant Protein (Mouse)

RP114710 100 ug Ask for price

Lenti ORF clone of Afmid (Myc-DDK-tagged ORF) - Rat arylformamidase (Afmid), (10 ug)

RR205855L3 10 µg Ask for price

Afmid ORF Vector (Rat) (pORF)

ORF063162 1.0 ug DNA
EUR 607.2

Rabbit anti-Danio rerio (Zebrafish)(Brachydanio rerio) afmid Polyclonal Antibody

MBS7195314-INQUIRE INQUIRE Ask for price

Lenti ORF particles, Afmid (Myc-DDK-tagged ORF) - Rat arylformamidase (Afmid), 200ul, >10^7 TU/mL

RR205855L3V 200 µl Ask for price

AFMID ORF Vector (Human) (pORF)

ORF012170 1.0 ug DNA
EUR 424.8

Afmid ORF Vector (Mouse) (pORF)

ORF038238 1.0 ug DNA
EUR 607.2

Human Arylformamidase (AFMID) Protein

20-abx652587
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Arylformamidase (AFMID) Protein

abx652587-100g 100 µg Ask for price

Human Arylformamidase (AFMID) Protein

abx652587-10g 10 µg
EUR 1800

Human Arylformamidase (AFMID) Protein

abx652587-50g 50 µg
EUR 4525

Lenti-ORF clone of AFMID (mGFP-tagged)-Human arylformamidase (AFMID), transcript variant 1

RC227526L4 10 µg Ask for price

Human AFMID knockout cell line

ABC-KH0369 1 vial Ask for price
Description: Human AFMID knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human AFMID knockdown cell line

ABC-KD0369 1 vial Ask for price
Description: Human AFMID knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human AFMID Protein Lysate 20ug

IHUAFMIDPLLY20UG each
EUR 213
Description: Human AFMID Protein Lysate 20ug

AFMID ELISA Kit (Human) (OKCD02010)

OKCD02010 96 Wells
EUR 997.2
Description: Description of target: Catalyzes the hydrolysis of N-formyl-L-kynurenine to L-kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.57 ng/mL

Lenti-ORF clone of AFMID (Myc-DDK-tagged)-Human arylformamidase (AFMID), transcript variant 1

RC227526L3 10 µg Ask for price

ELISA Kit for Arylformamidase (AFMID)

SEJ665Hu 96Т
EUR 700

Human Arylformamidase (AFMID) CLIA Kit

20-abx495758
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Arylformamidase (AFMID) ELISA Kit

20-abx150744
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Arylformamidase (AFMID) ELISA Kit

DLR-AFMID-Hu 96T
EUR 463
Description: tissue homogenates, cell lysates or other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

DLR-AFMID-Hu-48T 48T
EUR 620.4
Description: A sandwich quantitative ELISA assay kit for detection of Human Arylformamidase (AFMID) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

DLR-AFMID-Hu-96T 96T
EUR 807.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Arylformamidase (AFMID) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

EKN43693-48T 48T
EUR 378.7

Human Arylformamidase (AFMID) ELISA Kit

EKN43693-5x96T 5x96T
EUR 2569.75

Human Arylformamidase (AFMID) ELISA Kit

EKN43693-96T 96T
EUR 541

Human Arylformamidase (AFMID) ELISA Kit

EKU02582-48T 48T
EUR 555.66

Human Arylformamidase (AFMID) ELISA Kit

EKU02582-5x96T 5x96T
EUR 3770.55

Human Arylformamidase (AFMID) ELISA Kit

EKU02582-96T 96T
EUR 793.8

Human AFMID(Arylformamidase) ELISA Kit

ELK4511-48T 48T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human AFMID. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human AFMID. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human AFMID, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human AFMID in the samples is then determined by comparing the OD of the samples to the standard curve.
Conclusions: Our dengue immune standing algorithm can equip surveillance operations with the means to focus on dengue management efforts. The algorithm precisely recognized main dengue infections who’re vulnerable to future extreme illness.
Shelby

Be First to Comment

Leave a Reply

Your email address will not be published.